Vascular endothelial growth factor can substitute for macrophage colony- stimulating factor in the support of osteoclastic bone resorption

Journal of Experimental Medicine

Volumn 190, Issue 2, 1999, Pages 293-298

  Niida, Shumpei ^a   Kaku, Masato ^a   Amano, Hitoshi ^b   Yoshida, Hisahiro ^c   Kataoka, Hiroshi ^c   Nishikawa, Satomi ^c   Tanne, Kazuo ^a   Maeda, Norihiko ^a   Nishikawa, Shin Ichi ^c   Kodama, Hiroaki ^d  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d BAYER YAKUHIN LTD   (Japan)

Author keywords

Macrophage colony stimulating factor; Osteoclasts; Osteopetrosis; Vascular endothelial growth factor; Vascular endothelial growth factor receptor

Indexed keywords

COLONY STIMULATING FACTOR 1; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MICE, MUTANT STRAINS; MUTATION; OSTEOCLASTS; OSTEOPETROSIS; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033584243     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.2.293     Document Type: Article

References (37)

1. Marks, S.C., Jr., and P.W. Lane. 1976. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J. Hered. 67:11-18.
2. Marks, S.C., Jr. 1982. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice. Am. J. Anat. 163:157-167.
3. Wiktor-Jedrzejczak, W., A. Ahmed, C. Szczylik, and R.R. Skelly. 1982. Hematological characterization of congenital osteopetrosis in op/op mouse. J. Exp. Med. 156:1516-1527.
4. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okumura, T. Sudo, L.D. Shultz, and S.-I. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:442-444.
5. Felix, R., M.G. Cecchini, and H. Fleisch. 1990. Macrophage colony-stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology. 127:2592-2594.
6. Kodama, H., A. Yamasaki, M. Nose, S. Niida, Y. Ohgame, M. Abe, M. Kumegawa, and T. Suda. 1991. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J. Exp. Med. 173:269-272.
7. Wiktor-Jedrzejczak, W., E. Urbanowska, S.L. Aukerman, J.W. Pollard, E.R. Stanley, P. Ralph, A.A. Ansari, K.W. Sell, and M. Szperl. 1991. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp. Hematol. 19:1049-1054.
8. Sundquist, K.T., M.G. Cecchini, and S.C. Marks, Jr. 1995. Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone. 16:39-46.
9. Kodama, H., M. Nose, S. Niida, and A. Yamasaki. 1991. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J. Exp. Med. 173:1291-1294.
10. Hofstetter, W., A. Wetterwald, M.C. Cecchini, R. Felix, H. Fleisch, and C. Mueller. 1992. Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc. Natl. Acad. Sci. USA. 89:9637-9641.
11. Begg, S.K., J.M. Radley, J.W. Polland, O.T. Chisholm, E.R. Stanley, and I. Bertoncello. 1993. Delayed hematopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177:237-242.
12. Kodama, H., A. Yamasaki, M. Abe, S. Niida, Y. Hakeda, and H. Kawashima. 1993. Transient recruitment of osteoclasts and expression of their function in osteopetrotic (op/op) mice by a single injection of macrophage colony-stimulating factor. J. Bone Miner. Res. 8:45-50.
13. Niida, S., N. Amizuka, F. Hara, H. Ozawa, and H. Kodama. 1994. Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor. J. Bone Miner. Res. 9:873-881.
14. MacDonald, B.R., G.R. Mundy, S. Clark, E.A. Wang, T.J. Kuehl, E.R. Stanley, and D. Roodman. 1986. Effects of recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner. Res. 1:227-233.
15. Kurihara, N., T. Suda, Y. Miura, H. Nakauchi, H. Kodama, K. Hiura, Y. Hakeda, and M. Kumegawa. 1989. Generation of osteoclasts from isolated hematopoietic progenitor cells. Blood. 74:1295-1302.
16. Takahashi, N., N. Udagawa, T. Akatsu, H. Tanaka, M. Shionome, and T. Suda. 1991. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6:977-985.
17. Wiktor-Jedrzejczak, W., E. Urbanowska, and M. Szperl. 1994. Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient of op/op mouse. Endocrinology. 134:1932-1935.
18. Nilsson, S.K., G.J. Lieschke, C.C. Garcia-Wijnen, B. Williams, D. Tzelepis, G. Hodgson, D. Grail, A.R. Dunn, and I. Bertoncello. 1995. Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse. Blood. 86:66-72.
19. Myint, Y.Y., K. Miyakawa, M. Naito, L.D. Shultz, Y. Oike, K.-I. Yamamura, and K. Takahashi. 1999. Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation. Am. J. Pathol. 154:553-566.
20. Kondo, K., S. Hiratsuka, E. Subbalakshmi, H. Matsushime, and M. Shibuya. 1998. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors. Gene. 208:297-305.
21. Neufeld, G., T. Cohen, S. Gengrinovitch, and Z. Poltorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9-22.
22. Berleon, B., S. Sozzani, D. Shou, H.A. Weich, A. Mantovani, and D. Marmé. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 87:3336-3343.
23. Clauss, M., H. Weich, G. Breier, U. Knies, W. Röckl, J. Waltenberger, and W. Risau. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implication for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271:17629-17634.
24. Park, J.E., H.H. Chen, J. Winer, K.A. Houck, and N. Ferrara. 1994. Placenta growth-factor. Potentiation of vascular endothelial growth-factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 169:25646-25654.
25. Sawano, A., T. Takahashi, S. Yamaguchi, M. Aonuma, and M. Shibuya. 1996. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ. 7:213-221.
26. Hiratsuka, S., O. Minowa, J. Kuno, T. Noda, and M. Shibuya. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA. 95:9349-9354.
27. Sudo, T., S. Nishikawa, M. Ogawa, H. Kataoka, N. Ohno, A. Izawa, S.-I. Hayashi, and S.-I. Nishikawa. 1995. Hierarchical relation of c-kit and c-fms in intramarrow production of CFU-M. Oncogene. 11:2469-2476.
28. Kataoka, H., N. Takakura, S. Nishikawa, K. Tsuchida, H. Kodama, T. Kunisada, W. Risau, T. Kita, and S.-I. Nishikawa. 1997. Expression of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 39:729-740.
29. Ly, I.A., and R.I. Mishell. 1974. Separation of mouse spleen cells by passage through column of Sephadex G-10. J. Immunol. Methods. 5:239-247.
30. Amano, H., S. Yamada, and R. Felix. 1998. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J. Bone Miner. Res. 13:846-853.
31. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S.-I. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Prof. Natl. Acad. Sci. USA. 95:3597-3602.
32. Lacey, D.L., E. Timms, H.L. Tan, M.J. Kelley, C.R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:165-176.
33. Hamilton, W.J., and H.W. Mossman. 1976. Hamilton, Boyd and Mossman's Human Embryology. 4th ed. The Macmillan Press Ltd., London. 526-547.
34. 3 on osteoclasts are enhanced by vascular endothelial growth factor produced by osteoclasts and by growth factors produced by endothelial cells. Endocrinology. 138:2953-2962.
35. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:435-439.
36. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea, L. Powell-Braxton, K.J. Hillan, and M.W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:439-442.
37. Fong, G.H., J. Rossant, M. Gertsenstein, and M.L. Breitman. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 376:66-70.